Acheson, Liam S and Ezard, Nadine and Lintzeris, Nicholas and Dunlop, Adrian and Brett, Jonathan and Rodgers, Craig and Gill, Anthony and Christmass, Michael and McKetin, Rebecca and Farrell, Michael and Shoptaw, Steve and Siefried, Krista J (2022) Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibility and safety trial. Drug and Alcohol Dependence, 241, 109692. doi: 10.1016/j.drugalcdep.2022.109692.

Brett, Jonathan (2022) NDARC webinar series presentation. Non-opioid prescription misuse - new kids on the block. National Drug and Alcohol Research Centre.

Fletcher, Kathryn and Ezard, Nadine and Siefried, Krista J and MacDonald, Harriet and Acheson, Liam and Bedi, Gillinder and Guerin, Alexandre and Knock, Elizabeth and Millard, Michael and May, Robert and Brett, Jonathan and Doumany, Jess and Morgan, Celia and Clifford, Brendan (2025) Protocol of an open-label safety and feasibility pilot study of ketamine-assisted psychotherapy for methamphetamine use disorder (the KAPPA trial). BMJ Open, 15, (2), e092504. https://doi.org/10.1136/bmjopen-2024-092504.

Murnion, Bridin and Schaffer, Andrea and Cairns, Rose and Brett, Jonathan (2022) Gabapentinoids: repeating mistakes of the past? Addiction, 117, (12), pp. 2969-2971. doi: 10.1111/add.15970.

Schölin, Lisa and Humphries, Chris and Eddleston, Michael and Brennan, Gearóid and Lloyd, Adam and Reed, Matthew J and Bryan, Michael E and Smith, Linda J and Brett, Jonathan (2025) De-siloing substance misuse and self-harm research through integrated public health and emergency medicine. The Lancet Public Health, Early online, DOI: 10.1016/S2468-2667(25)00096-9.

Williams, Andrew James and Schӧlin, Lisa and Brett, Jonathan (2024) Treatments for stimulant use disorder – a rapid review for policy makers and practitioners. Edinburgh: Drugs Research Network Scotland.